You can buy or sell Chimerix and other stocks, options, ETFs, and crypto commission-free!
Chimerix, Inc. Common Stock, also called Chimerix, is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Read More Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.
Durham, North Carolina
52 Week High
52 Week Low
Seeking AlphaMay 9
Chimerix's (CMRX) CEO Mark Iwicki on Q1 2019 Results - Earnings Call Transcript
Chimerix, Inc. (NASDAQ:CMRX) Q1 2019 Earnings Conference Call May 9, 2019 8:30 AM ET Company Participants Michelle LaSpaluto – Investor Relations Mike Sherman – President and Chief Executive Officer Garrett Nichols – Chief Medical Officer Tim Trost – Chief Financial Officer Mike Andriole – Chief Business Officer Conference Call Participants Ed White – H.C. Kenneth Atkins – Cowen Operator Good morning. Welcome to the Chimerix conference call discussing the financial results of the first quarter of...
Expected Aug 8, Pre-Market